Videos and Podcasts

4th May 20

Pharmaxic CEO Gary Phillips Presentation to NWR Virtual Health Conference

Pharmaxis Ltd (ASX: PXS) chief executive officer Mr Gary Phillips presented at the NWR Virtual Health Conference on Friday 1 May 2020. 

Investors may view a recording of the presentation at the NWR website:

30th Apr 20

Pharmaxis to progress myelofibrosis drug to Phase II following positive results

Gary Phillips tells Proactive's Andrew Scott they're progressing to a phase II study of its oral anti-fibrotic pan-Lysyl Oxidase (LOX) inhibitor PXS-5505 for treatment of the rare bone cancer, myelofibrosis (MF). The move comes on the back of positive results from its phase 1b trial and long-term toxicity studies.

Watch interview